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Background. In 2015, pneumonia remained the leading cause of mortality in children aged 1–59 months.
Methods. Data from 1802 human immunodeficiency virus (HIV)–negative children aged 1–59  months enrolled in the 
Pneumonia Etiology Research for Child Health (PERCH) study with severe or very severe pneumonia during 2011–2014 were used 
to build a parsimonious multivariable model predicting mortality using backwards stepwise logistic regression. The PERCH severity 
score, derived from model coefficients, was validated on a second, temporally discrete dataset of a further 1819 cases and compared 
to other available scores using the C statistic.
Results. Predictors of mortality, across 7 low- and middle-income countries, were age <1 year, female sex, ≥3 days of illness prior to 
presentation to hospital, low weight for height, unresponsiveness, deep breathing, hypoxemia, grunting, and the absence of cough. The 
model discriminated well between those who died and those who survived (C statistic = 0.84), but the predictive capacity of the PERCH 
5-stratum score derived from the coefficients was moderate (C statistic = 0.76). The performance of the Respiratory Index of Severity 
in Children score was similar (C statistic = 0.76). The number of World Health Organization (WHO) danger signs demonstrated the 
highest discrimination (C statistic = 0.82; 1.5% died if no danger signs, 10% if 1 danger sign, and 33% if ≥2 danger signs).
Conclusions. The PERCH severity score could be used to interpret geographic variations in pneumonia mortality and etiology. 
The number of WHO danger signs on presentation to hospital could be the most useful of the currently available tools to aid clinical 
management of pneumonia.
Keywords. prognosis/prognostic scores; severity index; pneumococcal disease; respiratory disease; pneumonia.
In 2015, pneumonia remained the leading cause of mortality 
in children between 1 month and 5 years of age, causing 12.8% 
of all deaths [1]. The etiology of an individual’s pneumonia is 
often difficult to ascertain, and clinical signs and symptoms are 
the only information available to inform treatment [2–5].
In 2013, the World Health Organization (WHO) 
recommended the reclassification of pneumonia cases into 
just 2 strata to inform treatment in resource-limited settings 
(Supplementary Table 1) [5, 6]. This dichotomous classification 
does not allow us to control well for severity in pneumonia eti-
ology studies across different geographical settings or to inform 
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treatment. A number of scoring systems have been developed 
that attempt to further stratify cases by severity. However, these 
use data from single African sites with unknown generalizability 
[4, 7, 8]; the Respiratory Index of Severity in Children (RISC) 
was derived from South African clinical trial participants aged 
1–23  months hospitalized for respiratory tract infection [4]. 
Additionally, WHO’s Pocketbook of Hospital Care for Children 
identifies common danger signs in hospitalized children that 
may indicate severity of disease and deterioration of condition.
To fulfill an original objective of the Pneumonia Etiology 
Research for Child Health (PERCH) study [9], we used data 
collected prospectively in 2011–2014 in 7 low- and middle-
income countries (LMICs), to develop and validate a severity 
score (“PERCH score”) to standardize the definition of pneu-
monia case severity for etiology analyses. To assess whether 
this score might aid clinical management of pneumonia cases, 
we compared the performance of this PERCH score with other 
available scores and classifications.
METHODS
Study Population
The PERCH study aimed to determine the etiology of pneu-
monia in children aged 1–59 months presenting to hospital 
[9]. Cases were eligible for enrollment if they were admitted 
to a study hospital with severe or very severe pneumonia, 
according to the 2005 WHO definitions (Supplementary 
Table 1), at 9 centers in Kenya, Zambia, South Africa, Mali, 
The Gambia, Bangladesh, and Thailand [10]. Standardized 
questionnaires and diagnostics were used across all sites [11, 
12]. Clinical data were obtained at the time of admission to 
hospital, and mortality status was obtained in hospital or 
30 days after discharge.
Of the 4232 pneumonia cases enrolled into the PERCH 
study, data from those who tested HIV negative (n  =  3596) 
and those without an HIV test result but presumed negative 
based on parental report (n = 366) were used for model de-
velopment and validation. Participants missing mortality data 
(8.6%) were similar in baseline characteristics to those with 
mortality data, but predominantly came from 1 site (Zambia; 
Supplementary Table 8).
Data from participants with information on the outcome 
(n  =  3621) were split in half; the first half (enrolled August 
2011–mid-November 2012; n = 1802) was used to develop the 
model, and the second half (enrolled mid-November 2012–
January 2014; n = 1819) was used to validate the model. A tem-
poral split allowed some non-random variation between the 
datasets and provided a stronger design for the validation of the 
model [13].
A total of 1802 HIV-negative cases in the development 
dataset and 120 deaths allowed us to produce a robust model 
containing ≤12 variables [14, 15].
Model Development
The primary outcome of “death in hospital or within 7 days of 
discharge,” regardless of the duration of admission, included 
children who died during admission or after discharge home 
for convalescent care or to a higher-level facility. From the list 
of PERCH variables [11], potentially predictive covariates for 
death and/or pneumonia severity were identified, informed by 
previous literature [11, 16, 17], including sociodemographic 
characteristics, medical history, anthropometrics, the results of 
clinical examination and diagnostic tests, and environmental 
exposures. Variables with >25% missing data (eg, medication 
history, gestational age, weak pulse) were excluded from the 
analysis. A  total of 54 variables were assessed in univariable 
analyses; “country site” was used as a forced variable to iden-
tify the strongest predictors of the outcome, controlling for 
clustering.
Covariates associated with mortality in univariable analyses 
with P < .2 were included in multivariable regression models. 
If multiple potentially collinear variables were strongly associ-
ated with the outcome (eg, the anthropometric variables), then 
clinical insight was used to choose the most practical variable to 
include [18]. The number of variables in the model was reduced 
using backwards stepwise logistic regression. Interactions 
between all the variables in the final model were assessed. 
Variables and interaction terms were kept in the model if they 
significantly improved the fit of the model (likelihood ratio test 
[LRT], P < .05). Each excluded variable was re-added to the final 
model to ensure the final model fit the data best.
Evaluation of Model Performance
The forced variable of “site” was removed from the model to 
evaluate the performance of the model in the absence of infor-
mation on clustering, as this is unlikely to be available in clinical 
settings. The ability of the model to discriminate between those 
who died and who survived was assessed using the C statistic, 
equivalent to the area under the receiver operating character-
istic curve [19]. The C statistic ranges from 0.5 to 1; 0.5 indicates 
that the model is unable to discriminate beyond random chance 
[20]. A C statistic >0.8 was a priori defined as a good fit of the 
model to the data; >0.7 was defined as a moderate fit.
PERCH Score Development and Temporal Validation
Each covariate’s coefficient on the log scale in the final model, 
excluding “site,” was rounded to the nearest 0.5 and then 
doubled to form an integer [4, 21, 22]. Five strata of severity, 
the “5-stratum score,” were developed by splitting the score into 
quintiles of roughly equal size.
The PERCH score was then computed for each record with 
complete data on all the score variables in the validation dataset. 
The ability of the 5-stratum score to discriminate between those 
who died and those who survived was assessed using the C sta-
tistic; bootstrapping with 200 repetitions was used to adjust for 
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optimism [19, 21, 23]. The model’s calibration was assessed by 
visually comparing the predicted risk of death using the logistic 
regression model, with the observed deaths.
Cases in the validation dataset were also categorized according 
to 3 other severity classifications: (1) WHO 2005 definitions of 
severe pneumonia or very severe pneumonia [24]; (2) the South 
Africa RISC score [4]; and (3) the number of danger signs from 
the WHO Pocketbook of Hospital Care for Children [24]. The 
RISC score for HIV-negative children [4] assigns scores for ≤90% 
oxygen saturation on pulse oximetry, lower chest wall indrawing, 
low weight for age, refusal to feed, and wheeze (Supplementary 
Table 2). Danger signs included central cyanosis or oxygen satu-
ration <90% on pulse oximetry, inability to drink/feed, vomiting, 
convulsions, lethargy (or impaired consciousness), and severe 
respiratory distress [24]. The C statistics of the WHO 2005 clas-
sification, the RISC score, the number of danger signs, and the 
PERCH 5-stratum score were compared to determine the score 
most able to discriminate between those who died and those who 
survived. The calibration between predicted deaths and observed 
deaths was assessed visually. The positive and negative predic-
tive values of each of the scores were calculated by dividing the 
number of observed deaths by the number of predicted deaths. 
For this purpose, a predicted death was defined as a case with a 
predicted probability of death of ≥0.2, as no cases had a predicted 
probability of death ≥0.5.
The PERCH study was approved by the relevant ethics 
committee(s) overseeing each site and by the Johns Hopkins 
Bloomberg School of Public Health ethics committee. Written 
informed consent was obtained from parents/guardians prior to 
any study procedures.
RESULTS
Among the 1994 HIV-negative children in the develop-
ment dataset, 1802 (90.4%) had data on survival up to 7 days 
post-discharge. The median age at presentation to hospital 
was 9  months (interquartile range [IQR], 4–19  months), 
57% were male, the median duration of hospitalization was 
4 days (IQR, 3–7 days), and 120 (6.7%) died within 7 days 
of discharge. Most of the deaths (67/120 [56%]) occurred 
within 48 hours of admission; 46 died later during admis-
sion (range, 3–49  days), and 7 died within 7  days of being 
discharged home in a moribund state or to a higher-level fa-
cility. Mortality varied by country, from 1.5% in Bangladesh 
to 26.0% in Zambia (Table 1). Factors associated with mor-
tality among HIV-negative children aged 1–59  months 
presenting to hospital with severe or very severe pneumonia 
are shown in Supplementary Table 3. Presentation with at 
least 1 symptom of central cyanosis, hypoxemia, inability to 
feed, convulsions, or unresponsiveness was associated with 
4.8 times higher odds of death compared to those with no 
symptoms, controlling for site (95% confidence interval, 
3.02–7.63; Supplementary Table 3).
The Multivariable Predictive Model
Predictors of mortality in multivariable analyses, controlling for 
country, were younger age, female sex, >2 days of illness prior 
to presentation to hospital, low weight for height, unrespon-
siveness, deep breathing, hypoxemia, and grunting. Observed 
cough was predictive of survival (Table 1). Overall, mortality 
was slightly lower among the 1719 observations (95%) in the 
final model (6.2%) than in the overall population. The predic-
tive performance of the model as measured by the C statistic was 
good (C statistic = 0.86).
Assigned scores ranged from –1 to 16 (mean, 4.3 [standard 
deviation, 2.9]) (Table 2). The 5-stratum score performed well 
during internal validation on the development dataset (C sta-
tistic  =  0.82; Supplementary Figure 1). There was good cal-
ibration between the observed and predicted prevalence of 
mortality. In the highest stratum, the observed mortality was 
21%. The final model was rerun as a multilevel model with 
random effects to control for clustering. The point estimates 
were not substantially different from those generated using 
fixed effects. Fixed effects were used in the final model to allow 
for site-specific analyses.
Performance of PERCH Score on the Validation Dataset
Children in the validation dataset, who were HIV negative and 
had data on the outcome (n = 1819), were slightly younger than 
in the development dataset (median age, 7 vs 9  months) and 
mortality was higher (8%  vs 6.7%) (Supplementary Table 4). 
A total of 1755 of 1819 (96%) records in the validation dataset 
had data on all the variables included in the multivariable 
model. The predictive performance of the model in the vali-
dation dataset was good (C  statistic  =  0.84). The mean score 
allocated was similar to the development dataset (mean, 4.4 
[standard deviation, 2.8]; range, –1 to 16).
In the validation dataset, the 5-stratum score was able 
to discriminate moderately well between children who 
died and those who survived (C  statistic  =  0.76; Figure 1). 
After bootstrapping to adjust for optimism, the C statistic 
remained at 0.76. No children allocated to stratum 1 died; 
2.6% in strata 2 and 3 died; 7.1% in stratum 4 died; and 24% 
in stratum 5 died (Table 3). There was good calibration be-
tween the stratum-specific observed mortality and the mean 
predicted probabilities of mortality in the validation dataset, 
and they were similar to those in the development dataset 
(Supplementary Table 5). However, although the C statistic 
indicated that the score predicted the outcome across the 
population in the dataset moderately well, there was a large 
overlap in the total scores allocated to individuals who died 
and those who survived (Figure 1).
When the performance of the 5-stratum score was assessed 
by country, it performed moderately well in Zambia (C  sta-
tistic = 0.72) and The Gambia (C statistic = 0.74), but performed 
less well in Kenya, Mali, and a combined dataset of South 
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Africa, Bangladesh, and Thailand (C statistics = 0.64–0.70). The 
5-stratum score performed moderately well (C statistic = 0.74–
0.76) in all age groups except 6- to 11-month-olds, where its dis-
criminatory capacity dropped to 0.62 (Supplementary Table 6).
Comparison of Available Scores
Observed mortality ranged from 17% in those classified with the 
WHO 2005 definition of very severe pneumonia, to 33% among 
children with ≥2 danger signs on presentation to hospital (Table 3).
Table 1. Factors Predictive of Mortality Among Human Immunodeficiency Virus–negative Children 1–59 Months of Age Presenting to Hospital With 
Severe or Very Severe Pneumonia: Multivariable Analyses
Characteristic
Died Within 7 d of Discharge Unadjusted Adjusted
LRT P ValueaNo Yes ORa (95% CI) aOR (95% CI)
Allb 1682 (93.3) 120 (6.7) … … … …  
Site          
 Kenya 372 (96.6) 13 (3.4) 1.06 (.48–2.35) 1.13 (.41–3.11)  
 The Gambia 235 (95.5) 11 (4.5) 1.42 (.61–3.26) 2.13 (.73–6.27)  
 Mali 213 (86.6) 33 (13.4) 4.69 (2.37–9.27) 2.20 (.84–5.75)  
 Zambia 125 (74.0) 44 (26.0) 10.6 (5.45–20.8) 12.3 (5.13–29.7)  
 South Africa 363 (96.8) 12 (3.2) 1 (ref) 1 (ref)  
 Thailand 115 (97.5) 3 (2.5) 0.80 (.22–2.85) 0.77 (.09–6.69)  
 Bangladesh 259 (98.5) 4 (1.5) 0.47 (.15–1.46) 1.00 (.25–3.99)  
Age, mo          
 1–11 947 (91.9) 84 (8.1) 1.37 (.89–2.10) 2.20 (1.28–3.78) .0031
 12–59 735 (95.3) 36 (4.7) 1 (ref) 1 (ref)  
Sex          
 Male 974 (95.0) 51 (5.0) 1 (ref) 1 (ref) .0038
 Female 708 (91.1) 69 (8.9) 1.76 (1.19–2.61) 1.99 (1.24–3.20)  
Unresponsiveness and/or deep breathingc         
 Neither 1149 (95.2) 58 (4.8) 1 (ref) 1 (ref) <.0001
 Deep breathing, but alert 366 (95.8) 16 (4.2) 1.46 (.78–2.73) 1.18 (.58–2.39)  
 Unresponsive but no deep breathing 123 (83.7) 24 (16.3) 4.61 (2.60–8.19) 3.12 (1.51–6.45)  
 Unresponsive and deep breathing 36 (62.1) 22 (37.9) 19.4 (9.74–38.8) 14.6 (6.53–32.8)  
Cough (observed)          
 No 498 (88) 68 (12) 1 (ref) 1 (ref) .0032
 Yes 1175 (95.8) 52 (4.2) 0.43 (.28–.65) 0.48 (.29–.78)  
Grunting (observed)          
 No 1414 (95.8) 62 (4.2) 1 (ref) 1 (ref) .0026
 Yes 257 (81.6) 58 (18.4) 2.77 (1.67–4.58) 2.48 (1.37–4.48)  
Hypoxemiad          
 No 1125 (95.7) 51 (4.3) 1 (ref) 1 (ref) .0002
 Yes 554 (88.9) 69 (11.1) 3.18 (2.08–4.86) 2.55 (1.54–4.22)  
Maximum duration of illness,e d         
 0–2 637 (96.5) 23 (3.5) 1 (ref) 1 (ref) .0018
 3–5 740 (93.4) 52 (6.6) 1.87 (1.11–3.15) 2.15 (1.16–3.99)  
 >5 291 (87.4) 42 (12.6) 3.21 (1.84–5.63) 3.28 (1.66–6.46)  
Weight-for-height z-score          
 Very low (< –3) 160 (82.5) 34 (17.5) 4.55 (2.75–7.55) 3.57 (2.03–6.31) <.0001
 Low (≥ –3 to < –2) 223 (91) 22 (9) 2.54 (1.47–4.41) 2.45 (1.32–4.52)  
 Normal-high (≥ –2) 1258 (96) 52 (4) 1 (ref) 1 (ref)  
Data are presented as no. (%) unless otherwise indicated.
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; d, days; LRT, likelihood ratio test; OR, odds ratio; ref, reference category.
aChildren presenting to hospital with cough or difficulty breathing (observed or history of) and observed lower chest wall indrawing or at least 1 danger sign from the World Health 
Organization Pocketbook of Hospital Care for children were enrolled into the Pneumonia Etiology Research for Child Health (PERCH) study. The full set of univariable analyses, including 
information on missing data, is included in Supplementary Table 3; factors displayed in this table are only those that remained in the final multivariable model. All analyses controlled for site 
using “site” as a forced, indicator variable. P values were obtained from logistic regression LRT. During backwards regression modeling, covariates were removed from the model if they 
did not significantly improve the fit of the model to the data (P > .05). When variables associated with the outcome in univariable analyses were added back into the model, they did not 
significantly increase the fit of the model to the data. When the model was run using random effects to control for clustering rather than logistic regression estimating fixed effects for each 
site, the coefficients were identical to those above and the allocated scores were the same.
bA total of 1719 of 1802 observations were used in the final model (95%); observations with missing data were significantly associated with higher mortality (χ2 P < .05), and their omission 
from the final model reduced the overall mortality from 6.7% to 6.2%.
cLRT P value for interaction = .018.
dHypoxemia was defined as oxygen saturation <92% in all sites except Zambia and South Africa (the 2 sites situated at altitude >1000 m), where it was defined as <90%.
eMaximum reported duration of illness with fever, cough, difficulty breathing, or wheeze.
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The PERCH score (C  statistic  =  0.76), the RISC score 
(C  statistic  =  0.76), and the WHO 2005 classification (C  sta-
tistic = 0.73) had similar abilities to discriminate between those 
who died and those who survived. The number of danger signs 
on presentation to hospital demonstrated the highest discrim-
inatory capacity (C  statistic =  0.82; Table 3, Figure 1). When 
assessing both discrimination and calibration, the danger signs 
were most predictive of mortality, followed by the PERCH 
5-stratum score and RISC score; the WHO 2005 classification 
performed less well.
DISCUSSION
The model performed well and the 5-stratum severity score 
performed moderately well in predicting mortality when 
validated on a temporally discrete dataset. The ability of the 
PERCH 5-stratum score to discriminate between those chil-
dren who died and those who survived was similar to the RISC 
score in HIV-negative children but had slightly better positive 
and negative predictive values. Importantly, the observed mor-
tality in the lowest PERCH severity stratum was 0%—that is, 
the PERCH 5-stratum score performed well in identifying those 
who survived after admission to hospital. All PERCH cases 
were treated in hospital, so we cannot infer from this dataset 
Table 2. Pneumonia Etiology Research for Child Health Score
Characteristic
Adjusted Log  
Coefficient PERCH Scorea
Age, mo   
 1–11 0.79 +2
 12–59 … …
Sex   
 Male ...
 Female 0.69 +1
Unresponsiveness and/or deep breathing  
 Neither … …
 Deep breathing, but alert 0.16  +0
 Unresponsive but no deep breathing 1.14 +2
 Unresponsive and deep breathing 2.68 +5 
Cough (observed)   
 No … …
 Yes 0.74 –1
Grunting (observed)   
 No … …
 Yes 0.91 +2
Hypoxemiab   
 No … …
 Yes 0.94 +2
Maximum duration of illnessc   
 0–2 … …
 3–5 0.77 +2
 >5 1.19 +2 
Weight-for-height z-score   
 Very low (< –3) 1.27 +3
 Low (≥ –3 to < –2) 0.90 +2
 Normal-high (≥ –2) … …
Abbreviation: PERCH, Pneumonia Etiology Research for Child Health.
aThe PERCH severity score was calculated by doubling the rounded log coefficients from 
the multivariable model (rounded to the nearest 0.5).
bHypoxemia was defined as oxygen saturation <92% in all sites except Zambia and South 
Africa (the 2 sites situated at altitude), where it was defined as <90%.
cMaximum reported duration of illness with fever, cough, difficulty breathing, or wheeze.
Figure 1. Predictive performance of the Pneumonia Etiology Research for Child 
Health (PERCH) 5-stratum severity score in the validation dataset compared to the 
World Health Organization (WHO) 2005 severity definitions, the number of WHO 
danger signs, and the Respiratory Index of Severity in Children (RISC) score. A, 
Receiver operating characteristic curves of each score/classification: WHO 2005 
classification (the lowest, blue curve; area under the curve [AUC]  =  0.73), RISC 
score (the second-lowest, red curve; AUC = 0.76), PERCH score (third-lowest, gray 
curve; AUC = 0.76), and danger signs classification (top, green curve; AUC = 0.82). 
B, Frequency plot of the total PERCH scores allocated to cases who died and cases 
who survived. The dark green columns indicate the children assigned to the highest-
severity PERCH score stratum (stratum 5, with total scores between 7 and 17). The 
positive predictive value of the score indicates that 24% of children in the highest 
stratum (with a predicted probability of death of >0.2, dark green bars in the figure) 
actually died, ie, 24% of the dark green bars are in the right-hand panel. The spec-
ificity (79%) is the proportion of children who survived whose predicted probability 
of death was <0.2 (the children represented by light green in the left-hand panel, 
divided by the total number of children in the left-hand panel). The sensitivity (65%) 
is the proportion of children who died whose predicted probability of death was 
>0.2 (the children represented in dark green in the right-hand panel divided by the 
total in the right-hand panel). The negative predictive value indicates that 4.2% of 
children with a predicted probability of death <0.2 actually died.
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which cases may have been successfully managed at home; this 
would have to be the subject of a new clinical trial.
When all PERCH cases were assigned to a PERCH se-
verity stratum, the sites with the highest mortality correlated 
with those with the highest proportion of cases in the highest-
severity stratum (Mali, Zambia; Supplementary Table 7).
In children presenting with WHO-defined severe or very se-
vere pneumonia, observed cough was associated with survival, 
despite being a recognized sign of pneumonia. The absence of 
cough may indicate the presence of more severe signs of respira-
tory distress and/or severe weakness as the case defining feature, 
or the presence of sepsis, cerebral malaria, or meningitis, which 
are associated with higher mortality than pneumonia.
The utility of the available severity scores for clinicians in the 
management of childhood pneumonia is unclear, and the 2013 re-
vision of the WHO severity classifications and recommendations 
for clinical care has been challenged [25]. A large study of 16 000 
Kenyan children presenting to hospital with pneumonia found 
that 74% admitted to hospital under the WHO 2005 guidelines 
would have been classified as eligible for home treatment using 
the 2013 WHO guidelines; however, 3% of this group died after 
admission to hospital [17]. This finding is replicated in this 
Table 3. Calibration of Observed Versus Predicted Mortality in the Validation Dataset, by Score
Severity Strata
Observed Mortality, 
No. (%) Crude OR (95% CI)
Mean Predicted 
Mortality, %
C Statistic (Adjusted for 
Optimisma) PPVb NPVb
PERCH score stratac    
 –1 to 1 0/275 (0) … 1.0 0.76 (0.76) 23.6% 95.8%
 2 5/139 (3.6) (ref) 1.9
 3–4 13/560 (2.3) 0.64 (.22–1.82) 2.8 
 5–6 29/408 (7.1) 2.05 (.78–5.41) 6.8 
 7–17 88/373 (23.6) 8.28 (3.28–20.9) 23.1 
 Total 135/1755 … … … … … …
WHO 2005 classificationd    
 Severe 31/1145 (2.7) (ref) 2.7 0.73 (0.73) 0% 92.3%
 Very severe 104/610 (17.0) 7.39 (4.88–11.2) 17.0 
 Total 135/1755 … … … … … …
South Africa RISC stratae       
 –2 to 1 9/567 (1.6) (ref) 1.6 0.76 (0.76) 19.4% 95.6%
 2 15/440 (3.4) 2.19 (.95–5.05) 3.3 
 3 13/227 (5.7) 3.77 (1.59–8.94) 6.9 
 4 24/141 (17) 12.7 (5.76–28.1) 15 
 5–8 73/376 (19.4) 14.9 (7.37–30.3) 19.6 
 Total 134/1751 … … … … … …
WHO danger signs, No.f,g    
 0 14/916 (1.5) (ref) 1.5 0.82 (0.82) 32.5% 96.1%
 1 37/404 (9.2) 6.50 (3.47–12.2) 9.2
 ≥2 67/206 (32.5) 31.1 (17.0–56.8) 32.5
 Total 118/1526 … … … … … …
Abbreviations: CI, confidence interval; NPV, negative predictive value; OR, odds ratio; PERCH, Pneumonia Etiology Research for Child Health; PPV, positive predictive value; ref, reference 
category; RISC, Respiratory Index of Severity in Children; WHO, World Health Organization.
aOptimism is where the C statistic overestimates the score’s predictive ability due to overfitting of the model to the data, eg, when using a small dataset.
bAs the predicted probabilities of death assigned to cases using the score alone were all <0.5 (range, 0.02–0.24), a cutoff of >0.2 was used to define a predicted death to calculate PPV 
and NPV.
cThe decision to split the score into quintiles was set out in the statistical analysis plan and the split by frequency was computed using Stata software; groups are not exactly the same size 
given that we could not split groups of children assigned the same integer score. A total of 79 children were assigned a PERCH score of ≥10; observed mortality in this group was 42%. 
Of the 5 children who died with a PERCH score of 2, 3 were female, 2 were classified as very severe pneumonia, 4 were 12–59 months old, all were normal-high weight for height; 1 was 
lethargic, and 2 had <92% oxygen saturation at admission.
dSevere pneumonia is defined as cough/difficulty breathing and lower chest wall indrawing (LCWI); very severe pneumonia is cough/any difficulty breathing plus any one of the following 
danger signs: central cyanosis, inability to feed, vomiting everything, convulsions, lethargy, or severe respiratory distress (head nodding or grunting). Note that oxygen concentration was 
not used in the definition of very severe pneumonia.
eCharacteristics included in the RISC score included oxygen saturation <90%, LCWI, low weight for age, refusal to feed, and wheeze. The validation dataset exhibited higher observed mor-
tality than seen in the South African data from which the score was developed [1].
fWHO danger signs were defined as central cyanosis or oxygen saturation <90% on pulse oximetry, inability to drink/feed, vomiting everything, convulsions, lethargy/unresponsiveness or 
impaired consciousness, and severe respiratory distress (head nodding). The severity of chest wall indrawing was not noted in the dataset and therefore “severe chest wall indrawing” could 
not be included as a danger sign; all of those cases categorized with no danger signs displayed some LCWI (as it was a requirement for study eligibility [severe or very severe pneumonia 
as per WHO 2005 guidelines]). The sample size used to assess the performance of the PERCH, RISC, and WHO scores was larger than that possible to use for the danger signs score due 
to missing data on some of the danger signs. When restricted to only the population with a score based on danger signs, the C statistics were as follows: PERCH score, 0.79; WHO 2005 
score, 0.75; RISC score, 0.81.
gOf the 14 children with no danger signs who died, 9 (65%) were female; 11 (79%) were aged 1–11 months; 10 (72%) were low/very low weight for height; 11 (79%) had illness duration 
for ≥3 days before presenting to hospital; none exhibited lethargy or unresponsiveness; only 3 were hypoxic (<92% oxygen); 9 (64%) had a cough. A total of 6 (43%) were in the highest 
PERCH risk stratum, and the remainder were equally distributed between the 3 other PERCH strata (not the lowest risk stratum with 0% mortality).
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analysis where 2.7% of children in the WHO 2005 severe cate-
gory died after admission to hospital. The WHO 2005 classifica-
tion of severe or very severe pneumonia performed least well in 
predicting mortality in the PERCH data.
The number of danger signs on presentation to hospital 
demonstrated the best ability to discriminate between those who 
survived and those who died when both ease of use and per-
formance are considered. Few (1.5%) children who presented 
with no danger signs died, and the proportion of those children 
assigned to the highest stratum of severity who actually did die 
was the highest across the scores. These findings reinforce the 
utility of the WHO danger signs, including pulse oximetry, in 
the clinical management of pneumonia cases across diverse 
settings.
The methods used to develop the model and PERCH severity 
score are comparable to those used elsewhere [4] and adhere 
to standardized guidelines on the development and validation 
of multivariable prediction models for individual prognosis 
(Transparent Reporting of a Multivariable Prediction Model for 
Individual Prognosis or Diagnosis [TRIPOD] statement) [13]. 
We were able to assess a very large selection of variables, and 
our model identified similar factors to those identified in other 
pneumonia severity scores [4, 7, 8, 17]. The triage and treat-
ment of pneumonia cases was standardized across countries to 
minimize the impact of indicator bias on mortality risk [15]. 
However, there were some differences; for example, the South 
African site administered oxygen to almost all cases on arrival, 
whereas other sites used pulse oximetry, if available, to guide 
oxygen administration. “Hypoxemia” in this analysis was de-
fined using pulse oximetry or being on oxygen on arrival; the 
prevalence of hypoxemia at the South African site  (78%) was 
therefore overestimated, which may have underestimated the 
contribution of “true” hypoxemia to mortality.
As the PERCH pneumonia severity model was derived from 
cases hospitalized with cough/difficulty breathing and either 
lower chest wall indrawing or danger signs, we cannot infer its 
performance among all cases of lower respiratory tract infec-
tion presenting to hospital, or among pneumonia cases treated 
in the community. The utility of the PERCH score needs to be 
validated with other, external datasets. Changes in etiology may 
influence severity, which may limit the utility of any score over 
time. Malaria tests were not relevant in all PERCH sites, and 
this limited the sample size with which to assess the importance 
of malaria in predicting mortality. In malaria-endemic sites 
(Kenya, The Gambia, Mali, and Zambia), 6.8% of the 44 HIV-
negative children with a positive slide for malaria died within 
7 days of discharge, compared to 9.8% of 989 with a negative 
slide (P = .5).
Risk factors for severe pneumonia and pneumonia mor-
tality differ with HIV status. Developing a severity score for 
HIV-negative cases only (due to the limited number of HIV-
positive cases, n = 251) restricts the utility of the PERCH score 
to clinical settings and studies where HIV status is known or 
where HIV prevalence is very low. WHO guidelines indi-
cate that any HIV-positive child with suspected pneumonia 
should be hospitalized; therefore, the added utility of a severity 
score to triage HIV-positive cases is low. However, a study in 
Malawi found that 73% of cases of pneumonia presenting 
to hospital during 2011–2014 were missing information on 
HIV status [7]. Additionally, pulse oximetry is unavailable in 
many settings; only 50% of patients underwent oxygen satura-
tion measurements in one observational study of routine care 
in Kenya [17]. Hypoxemia was strongly associated with mor-
tality in this model (Supplementary Table 3) and others [4, 7], 
reinforcing the clinical utility of pulse oximetry.
CONCLUSIONS
The 5-stratum severity score, derived from PERCH data on 
cases hospitalized with severe or very severe pneumonia in 
7 LMICs, performed moderately well in predicting mortality 
in HIV-negative children. The lowest risk stratum predicted 
survival well, with no observed mortality. The PERCH score 
could be used to control for severity in analyses of geo-
graphic variations in pneumonia etiology. When compared 
to all available scores, the number of danger signs was most 
predictive of mortality and could be the most useful, of the 
currently available tools, to aid clinical management of pneu-
monia cases.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases on-
line. Consisting of data provided by the authors to benefit the reader, the 
posted materials are not copyedited and are the sole responsibility of the 
authors, so questions or comments should be addressed to the corre-
sponding author.
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